▶ 調査レポート

世界のオピオイド誘発性便秘治療市場:市場規模・現状・予測

• 英文タイトル:Global Opioid Induced Constipation Treatment Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界のオピオイド誘発性便秘治療市場:市場規模・現状・予測 / Global Opioid Induced Constipation Treatment Market Size, Status and Forecast 2019-2025 / QYR9N7709資料のイメージです。• レポートコード:QYR9N7709
• 出版社/出版日:QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、94ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医療・製薬・バイオ
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当資料は、オピオイド誘発性便秘治療のグローバル市場について調査・分析したレポートで、種類別(経口、非経口(皮下注射))、用途別(ドラッグストア、独立薬局、病院薬局)、主要地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米)の市場規模、市場予測、関連企業情報などが含まれています。

・オピオイド誘発性便秘治療の世界市場規模
・主要企業別市場シェア
・オピオイド誘発性便秘治療の世界市場規模:種類別(経口、非経口(皮下注射))
・オピオイド誘発性便秘治療の世界市場規模:用途別(ドラッグストア、独立薬局、病院薬局)
・オピオイド誘発性便秘治療のアメリカ市場規模(種類別、用途別)
・オピオイド誘発性便秘治療のヨーロッパ市場規模(種類別、用途別)
・オピオイド誘発性便秘治療の中国市場規模(種類別、用途別)
・オピオイド誘発性便秘治療の日本市場規模(種類別、用途別)
・オピオイド誘発性便秘治療の東南アジア市場規模(種類別、用途別)
・オピオイド誘発性便秘治療のインド市場規模(種類別、用途別)
・オピオイド誘発性便秘治療の中南米市場規模(種類別、用途別)
・主要企業別分析(企業概要、製品動向、販売量など)
・オピオイド誘発性便秘治療の世界市場予測(2019年-2025年)
・オピオイド誘発性便秘治療の地域別市場予測(2019年-2025年)
...

There are multiple drugs in the pipeline for opioid induced constipation treatment. Upon approval, these drugs will face little competition in this market which is largely untapped. There have not been many stable choices in the pharmaceutical industry for opioid induced constipation treatment over the recent past, but the continuous approval rate of highly targeted drugs is expected to provide a strong push to this market’s growth rate. In 2018, the global Opioid Induced Constipation Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Opioid Induced Constipation Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Opioid Induced Constipation Treatment development in United States, Europe and China.

The key players covered in this study
GlaxoSmithKline
AstraZeneca
Pfizer
S.L.A. Pharma
AIKO Biotechnology
Cubist Pharmaceuticals
Salix Pharmaceuticals
Takeda Pharmaceutical

Market segment by Type, the product can be split into
Oral
Parenteral (Subcutaneous Injection)

Market segment by Application, split into
Drug Store
Independent Pharmacies
Hospital Pharmacies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Opioid Induced Constipation Treatment status, future forecast, growth opportunity, key market and key players.
To present the Opioid Induced Constipation Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Opioid Induced Constipation Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Opioid Induced Constipation Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Oral
1.4.3 Parenteral (Subcutaneous Injection)
1.5 Market by Application
1.5.1 Global Opioid Induced Constipation Treatment Market Share by Application (2014-2025)
1.5.2 Drug Store
1.5.3 Independent Pharmacies
1.5.4 Hospital Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Opioid Induced Constipation Treatment Market Size
2.2 Opioid Induced Constipation Treatment Growth Trends by Regions
2.2.1 Opioid Induced Constipation Treatment Market Size by Regions (2014-2025)
2.2.2 Opioid Induced Constipation Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Opioid Induced Constipation Treatment Market Size by Manufacturers
3.1.1 Global Opioid Induced Constipation Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Opioid Induced Constipation Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Opioid Induced Constipation Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Opioid Induced Constipation Treatment Key Players Head office and Area Served
3.3 Key Players Opioid Induced Constipation Treatment Product/Solution/Service
3.4 Date of Enter into Opioid Induced Constipation Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Opioid Induced Constipation Treatment Market Size by Type (2014-2019)
4.2 Global Opioid Induced Constipation Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Opioid Induced Constipation Treatment Market Size (2014-2019)
5.2 Opioid Induced Constipation Treatment Key Players in United States
5.3 United States Opioid Induced Constipation Treatment Market Size by Type
5.4 United States Opioid Induced Constipation Treatment Market Size by Application

6 Europe
6.1 Europe Opioid Induced Constipation Treatment Market Size (2014-2019)
6.2 Opioid Induced Constipation Treatment Key Players in Europe
6.3 Europe Opioid Induced Constipation Treatment Market Size by Type
6.4 Europe Opioid Induced Constipation Treatment Market Size by Application

7 China
7.1 China Opioid Induced Constipation Treatment Market Size (2014-2019)
7.2 Opioid Induced Constipation Treatment Key Players in China
7.3 China Opioid Induced Constipation Treatment Market Size by Type
7.4 China Opioid Induced Constipation Treatment Market Size by Application

8 Japan
8.1 Japan Opioid Induced Constipation Treatment Market Size (2014-2019)
8.2 Opioid Induced Constipation Treatment Key Players in Japan
8.3 Japan Opioid Induced Constipation Treatment Market Size by Type
8.4 Japan Opioid Induced Constipation Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Opioid Induced Constipation Treatment Market Size (2014-2019)
9.2 Opioid Induced Constipation Treatment Key Players in Southeast Asia
9.3 Southeast Asia Opioid Induced Constipation Treatment Market Size by Type
9.4 Southeast Asia Opioid Induced Constipation Treatment Market Size by Application

10 India
10.1 India Opioid Induced Constipation Treatment Market Size (2014-2019)
10.2 Opioid Induced Constipation Treatment Key Players in India
10.3 India Opioid Induced Constipation Treatment Market Size by Type
10.4 India Opioid Induced Constipation Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Opioid Induced Constipation Treatment Market Size (2014-2019)
11.2 Opioid Induced Constipation Treatment Key Players in Central & South America
11.3 Central & South America Opioid Induced Constipation Treatment Market Size by Type
11.4 Central & South America Opioid Induced Constipation Treatment Market Size by Application

12 International Players Profiles
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline Company Details
12.1.2 Company Description and Business Overview
12.1.3 Opioid Induced Constipation Treatment Introduction
12.1.4 GlaxoSmithKline Revenue in Opioid Induced Constipation Treatment Business (2014-2019)
12.1.5 GlaxoSmithKline Recent Development
12.2 AstraZeneca
12.2.1 AstraZeneca Company Details
12.2.2 Company Description and Business Overview
12.2.3 Opioid Induced Constipation Treatment Introduction
12.2.4 AstraZeneca Revenue in Opioid Induced Constipation Treatment Business (2014-2019)
12.2.5 AstraZeneca Recent Development
12.3 Pfizer
12.3.1 Pfizer Company Details
12.3.2 Company Description and Business Overview
12.3.3 Opioid Induced Constipation Treatment Introduction
12.3.4 Pfizer Revenue in Opioid Induced Constipation Treatment Business (2014-2019)
12.3.5 Pfizer Recent Development
12.4 S.L.A. Pharma
12.4.1 S.L.A. Pharma Company Details
12.4.2 Company Description and Business Overview
12.4.3 Opioid Induced Constipation Treatment Introduction
12.4.4 S.L.A. Pharma Revenue in Opioid Induced Constipation Treatment Business (2014-2019)
12.4.5 S.L.A. Pharma Recent Development
12.5 AIKO Biotechnology
12.5.1 AIKO Biotechnology Company Details
12.5.2 Company Description and Business Overview
12.5.3 Opioid Induced Constipation Treatment Introduction
12.5.4 AIKO Biotechnology Revenue in Opioid Induced Constipation Treatment Business (2014-2019)
12.5.5 AIKO Biotechnology Recent Development
12.6 Cubist Pharmaceuticals
12.6.1 Cubist Pharmaceuticals Company Details
12.6.2 Company Description and Business Overview
12.6.3 Opioid Induced Constipation Treatment Introduction
12.6.4 Cubist Pharmaceuticals Revenue in Opioid Induced Constipation Treatment Business (2014-2019)
12.6.5 Cubist Pharmaceuticals Recent Development
12.7 Salix Pharmaceuticals
12.7.1 Salix Pharmaceuticals Company Details
12.7.2 Company Description and Business Overview
12.7.3 Opioid Induced Constipation Treatment Introduction
12.7.4 Salix Pharmaceuticals Revenue in Opioid Induced Constipation Treatment Business (2014-2019)
12.7.5 Salix Pharmaceuticals Recent Development
12.8 Takeda Pharmaceutical
12.8.1 Takeda Pharmaceutical Company Details
12.8.2 Company Description and Business Overview
12.8.3 Opioid Induced Constipation Treatment Introduction
12.8.4 Takeda Pharmaceutical Revenue in Opioid Induced Constipation Treatment Business (2014-2019)
12.8.5 Takeda Pharmaceutical Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Opioid Induced Constipation Treatment Key Market Segments
Table Key Players Opioid Induced Constipation Treatment Covered
Table Global Opioid Induced Constipation Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Opioid Induced Constipation Treatment Market Size Market Share by Type 2014-2025
Figure Oral Figures
Table Key Players of Oral
Figure Parenteral (Subcutaneous Injection) Figures
Table Key Players of Parenteral (Subcutaneous Injection)
Table Global Opioid Induced Constipation Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Drug Store Case Studies
Figure Independent Pharmacies Case Studies
Figure Hospital Pharmacies Case Studies
Figure Opioid Induced Constipation Treatment Report Years Considered
Table Global Opioid Induced Constipation Treatment Market Size 2014-2025 (Million US$)
Figure Global Opioid Induced Constipation Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Opioid Induced Constipation Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Opioid Induced Constipation Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Opioid Induced Constipation Treatment Market Share by Regions 2014-2019
Figure Global Opioid Induced Constipation Treatment Market Share by Regions 2014-2019
Figure Global Opioid Induced Constipation Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Opioid Induced Constipation Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Opioid Induced Constipation Treatment Market Share by Manufacturers (2014-2019)
Figure Global Opioid Induced Constipation Treatment Market Share by Manufacturers in 2018
Table Global Opioid Induced Constipation Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Opioid Induced Constipation Treatment Product/Solution/Service
Table Date of Enter into Opioid Induced Constipation Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Opioid Induced Constipation Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Opioid Induced Constipation Treatment Market Size Share by Type (2014-2019)
Figure Global Opioid Induced Constipation Treatment Market Size Market Share by Type (2014-2019)
Table Global Opioid Induced Constipation Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Opioid Induced Constipation Treatment Market Size Share by Application (2014-2019)
Figure Global Opioid Induced Constipation Treatment Market Size Market Share by Application (2014-2019)
Figure Global Opioid Induced Constipation Treatment Revenue Market Share by Application in 2018
Figure United States Opioid Induced Constipation Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Opioid Induced Constipation Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Opioid Induced Constipation Treatment Market Share (2018-2019)
Table United States Opioid Induced Constipation Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Opioid Induced Constipation Treatment Market Share by Type (2014-2019)
Table United States Opioid Induced Constipation Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Opioid Induced Constipation Treatment Market Share by Application (2014-2019)
Figure Europe Opioid Induced Constipation Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Opioid Induced Constipation Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Opioid Induced Constipation Treatment Market Share (2018-2019)
Table Europe Opioid Induced Constipation Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Opioid Induced Constipation Treatment Market Share by Type (2014-2019)
Table Europe Opioid Induced Constipation Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Opioid Induced Constipation Treatment Market Share by Application (2014-2019)
Figure China Opioid Induced Constipation Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Opioid Induced Constipation Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Opioid Induced Constipation Treatment Market Share (2018-2019)
Table China Opioid Induced Constipation Treatment Market Size by Type (2014-20189) (Million US$)
Table China Opioid Induced Constipation Treatment Market Share by Type (2014-2019)
Table China Opioid Induced Constipation Treatment Market Size by Application (2014-2019) (Million US$)
Table China Opioid Induced Constipation Treatment Market Share by Application (2014-2019)
Figure Japan Opioid Induced Constipation Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Opioid Induced Constipation Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Opioid Induced Constipation Treatment Market Share (2018-2019)
Table Japan Opioid Induced Constipation Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Opioid Induced Constipation Treatment Market Share by Type (2014-2019)
Table Japan Opioid Induced Constipation Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Opioid Induced Constipation Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Opioid Induced Constipation Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Opioid Induced Constipation Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Opioid Induced Constipation Treatment Market Share (2018-2019)
Table Southeast Asia Opioid Induced Constipation Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Opioid Induced Constipation Treatment Market Share by Type (2014-2019)
Table Southeast Asia Opioid Induced Constipation Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Opioid Induced Constipation Treatment Market Share by Application (2014-2019)
Figure India Opioid Induced Constipation Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Opioid Induced Constipation Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Opioid Induced Constipation Treatment Market Share (2018-2019)
Table India Opioid Induced Constipation Treatment Market Size by Type (2014-2019) (Million US$)
Table India Opioid Induced Constipation Treatment Market Share by Type (2014-2019)
Table India Opioid Induced Constipation Treatment Market Size by Application (2014-2019) (Million US$)
Table India Opioid Induced Constipation Treatment Market Share by Application (2014-2019)
Figure Central & South America Opioid Induced Constipation Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Opioid Induced Constipation Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Opioid Induced Constipation Treatment Market Share (2018-2019)
Table Central & South America Opioid Induced Constipation Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Opioid Induced Constipation Treatment Market Share by Type (2014-2019)
Table Central & South America Opioid Induced Constipation Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Opioid Induced Constipation Treatment Market Share by Application (2014-2019)
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Opioid Induced Constipation Treatment Business (2014-2019) (Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Opioid Induced Constipation Treatment Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2014-2019)
Table AstraZeneca Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Opioid Induced Constipation Treatment Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2014-2019)
Table Pfizer Recent Development
Table S.L.A. Pharma Company Details
Table S.L.A. Pharma Revenue in Opioid Induced Constipation Treatment Business (2014-2019)(Million US$)
Figure S.L.A. Pharma Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2014-2019)
Table S.L.A. Pharma Recent Development
Table AIKO Biotechnology Company Details
Table AIKO Biotechnology Revenue in Opioid Induced Constipation Treatment Business (2014-2019)(Million US$)
Figure AIKO Biotechnology Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2014-2019)
Table AIKO Biotechnology Recent Development
Table Cubist Pharmaceuticals Company Details
Table Cubist Pharmaceuticals Revenue in Opioid Induced Constipation Treatment Business (2014-2019)(Million US$)
Figure Cubist Pharmaceuticals Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2014-2019)
Table Cubist Pharmaceuticals Recent Development
Table Salix Pharmaceuticals Company Details
Table Salix Pharmaceuticals Revenue in Opioid Induced Constipation Treatment Business (2014-2019)(Million US$)
Figure Salix Pharmaceuticals Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2014-2019)
Table Salix Pharmaceuticals Recent Development
Table Takeda Pharmaceutical Company Details
Table Takeda Pharmaceutical Revenue in Opioid Induced Constipation Treatment Business (2014-2019)(Million US$)
Figure Takeda Pharmaceutical Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2014-2019)
Table Takeda Pharmaceutical Recent Development
Table Global Opioid Induced Constipation Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Opioid Induced Constipation Treatment Market Size Share by Regions (2019-2025)
Figure Global Opioid Induced Constipation Treatment Market Size Share by Regions in 2025
Figure United States Opioid Induced Constipation Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Opioid Induced Constipation Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Opioid Induced Constipation Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Opioid Induced Constipation Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Opioid Induced Constipation Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Opioid Induced Constipation Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Opioid Induced Constipation Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Opioid Induced Constipation Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Opioid Induced Constipation Treatment Market Size by Product (2019-2025)
Figure Global Opioid Induced Constipation Treatment Market Size by Product in 2025
Table Global Opioid Induced Constipation Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Opioid Induced Constipation Treatment Market Size by Application (2019-2025)
Figure Global Opioid Induced Constipation Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources